• Top ASX dividend shares to buy in August 2020

    fingers walking up piles of coins towards bag of cash signifying asx dividend shares

    fingers walking up piles of coins towards bag of cash signifying asx dividend sharesfingers walking up piles of coins towards bag of cash signifying asx dividend shares

    Along with our Top ASX Stock Picks for August, we also asked our Foolish writers to pick their favourite ASX dividend shares to buy this month.

    Here is what the team have come up with…

    Kate O’Brien: AGL Energy Limited (ASX: AGL)

    For a side of certainty with my dividends, I would be looking to AGL Energy. The company operates Australia’s largest energy portfolio, generating gas and electricity and selling it to end users. While COVID-19 may have shut down industries across Victoria, it can’t turn off demand for energy. This provides a degree of reliability for AGL’s earnings. AGL targets a dividend payout ratio of 75% and has predicted full year profits in the upper half of its guidance range. At the time of writing, the AGL share price is yielding 6.52% and is still around 20% down from its 2020 high. 

    Motley Fool contributor Kate O’Brien does not own shares in AGL Energy Limited. 

    Chris Chitty: Fortescue Metals Group Limited (ASX: FMG)

    Fortescue Metals Group has seen significant success recently as a result of a surging iron ore price. Not only is this company offering potential earnings growth, it has a trailing dividend yield of 5.44% fully franked (at the time of writing). In the financial year to 30 June 2020, Fortescue Metals shipped over 178 million tonnes of iron ore with C1 cash costs of just US$12.94, this is against a current iron ore spot price of more than US$100 per tonne. With China hungry for iron ore as it builds up its infrastructure, I believe Fortescue is in a great position to continue paying large dividends.

    Motley Fool contributor Chris Chitty does not own shares in Fortescue Metals Group Limited.

    Toby Thomas: Charter Hall Long WALE REIT (ASX: CLW)

    I’ve been keeping an eye on this real estate investment trust (REIT) for a while now, and think it could be a dividend harvester for a long time to come. Last week, the property trust announced its full-year results for FY20, which included a 5.2% rise in operating earnings and statutory profit of $122 million. The REIT currently pays out an annual dividend yield of around 5.8%, and is highly attractive for its average lease duration spanning a whopping 14 years. That provides long-term security for shareholders, who have the peace of mind knowing that blue-chip tenants such as  Woolworths Group Ltd (ASX: WOW), Telstra Corporation Ltd (ASX: TLS), BP and Coles Group Ltd (ASX: COL) will continue to pay rent for the foreseeable future.

    Motley Fool contributor Toby Thomas does not own shares in Charter Hall Long WALE REIT, Woolworths Group Ltd, Telstra Corporation Ltd or Coles Group Ltd.

    Lloyd Prout: CSL Limited (ASX: CSL)

    CSL is the largest company on the ASX, but it definitely isn’t the cheapest at approximately 46x earnings (at the time of writing). But, with around a 1% dividend yield and currently trading approximately 18% below its February highs, I think the CSL share price provides long-term investors a great total return opportunity.

    CSL’s plasma collections have been impacted by COVID-19, but over the long term the business should recover and the company should continue to grow earnings at a double-digit rate. The company also has a relatively low payout ratio of under 50%, providing room to grow the dividend even if earnings are flat.

    Motley Fool contributor Lloyd Prout does not own shares in CSL Limited and expresses his own opinion.

    Tristan Harrison: PM Capital Global Opportunities Fund Ltd (ASX: PGF) 

    PM Capital Global Opportunities Fund is a listed investment company (LIC) that invests in international shares which are usually unloved by the market.  

    It currently has a grossed-up dividend yield of around 6.1%, at the time of writing, and it has grown its dividend each year since 2016 when it started paying one. It has an outlook of growing dividends.  

    The LIC has diversified holdings like KKR & Co Inc, Visa Inc, Siemens AG and Freeport-McMoRan Inc. It’s also trading very cheaply – its share price is trading at around a 19% discount to the 31 July 2020 net tangible assets (NTA). I think it’s a good way to diversify your income stream.  

    Motley Fool contributor Tristan Harrison owns shares of PM Capital Global Opportunities Fund Ltd. 

    Daryl Mather: Charter Hall Retail REIT (ASX: CQR)

    The Charter Hall Retail REIT is focused on shopping centres like several other REITs. However, it is focused on neighbourhood and sub-regional centres. For example, the company owns a shopping centre in Albany, WA as well as Townsville, QLD. These centres are anchored by supermarkets and typically contain non-discretionary stores like chemists.

    I think the market has misjudged the impact of coronavirus on these assets. The REIT currently has a trailing 12-month dividend yield of around 6.2%. Its share price is down 24.24% year to date (at the time of writing) and it has a market capitalisation that is about 76% of its net tangible assets.

    Motley Fool contributor Daryl Mather does not own any shares of Charter Hall Retail REIT.

    Brendon Lau: Amcor PLC (ASX: AMC)

    The global packaging group may sound like an unexciting income share with a yield between 4%-5%, but unexciting is exactly what income investors need right now. Amcor’s earnings are expected to be relatively stable during the COVID-19 mayhem given its large exposure to the consumer staples and medical industries. This means it’s unlikely to cut its dividend. What’s more, unlike most other ASX 200 shares, Amcor pays its dividend quarterly.

    Motley Fool contributor Brendon Lau does not own shares of Amcor PLC. 

    Glenn Leese: Platinum Asset Management Ltd (ASX: PTM)

    Platinum Asset Management is a pooled investment sponsor. Essentially, it provides services to hedge and mutual funds by helping with launches and management. Platinum also invests in the share market directly, applying a value investing strategy across consumer, health care and technology sectors. With the current state of the world, these sectors are excellent targets.

    For more than 10 years, Platinum has delivered a stable and increasing dividend. The yield has nearly doubled since 2009, from 3.6% up to 6.99% at the time of writing, making it my top dividend stock pick.

    Motley Fool contributor Glenn Leese does not own any shares in Platinum Asset Management Ltd.

    Bernd Struben: Sonic Healthcare Limited (ASX: SHL)

    Sonic Healthcare Limited was established in 1987. Today, Sonic Healthcare is the world’s third largest pathology/laboratory medicine company with a market cap of around $16 billion. Based in Sydney, it operates in 8 countries.

    The company has an enviable track record of growing — or at the very least maintaining — its total dividend per share payout dating all the way back to 1994.

    The last interim dividend of 34 cents per share was paid on 25 March, for an annual dividend yield of 2.5%, partially franked at 30%.

    Atop its reliable dividends, the Sonic Healthcare share price has gained nearly 19% year to date.

    Motley Fool Contributor Bernd Struben does not own shares in Sonic Healthcare Limited.

    Michael Tonon: WAM Global Ltd (ASX: WGB)

    Not many companies are in the position to increase their current dividend payment, let alone announce a 100% increase. However, this is exactly what listed investment company (LIC) WAM Global has recently done.

    WAM Global is an LIC which manages a diversified portfolio of global companies. With the current increase in its final dividend, it now pays shareholders a 5% fully-franked dividend (grossed up), with enough profit reserves to cover this payment for at least the next 3 years.

    In addition, it has been growing its dividend rapidly since it began paying in 2019 and currently also trades at a ~12% discount to its net tangible assets (NTA) when compared to July’s before tax NTA of $2.28. 

    Motley Fool contributor Michael Tonon owns shares in WAM Global Ltd. 

    Matthew Donald: Charter Hall Long WALE REIT (ASX: CLW)

    Charter Hall Long WALE REIT has a diversified property portfolio across industrial & logistics, office, long WALE retail, telco exchange and agri-logistics sectors. Its strong tenants, which include government, ASX-listed and multinational companies, have helped the group deliver solid full year results announced last week.

    COVID-19 hasn’t had a significant impact on the business. Additionally, from FY17 it has been able to deliver an average distribution growth rate of 3% to FY20.

    Going forward, due to its diverse property portfolio and quality tenants, I believe the group will be able to deliver continued distribution growth to investors.

    Motley Fool contributor Matthew Donald does not own shares in Charter Hall Long WALE REIT.

    Phil Harpur: JB Hi-Fi Limited (ASX: JBH) 

    Electronics retailer JB Hi-Fi has continued to perform well financially, despite the challenges of the coronavirus pandemic. For the half year so far (to early June), JB Hi-Fi reported sales up 20% over the prior corresponding period. Demand has been particularly strong during the pandemic for technology products. I am particularly attracted to JB Hi-Fi as a retailer because its online channel is more developed than some of its other bricks and mortar competitors such as Harvey Norman Holdings Limited (ASX: HVN). Online sales have been booming during the crisis. JB Hi-Fi also pays a fully-franked forward dividend yield of around 3.3%.

    Motley Fool contributor Phil Harpur does not own shares in JB Hi-Fi Limited or Harvey Norman Holdings Limited.

    Sebastian Bowen: CSL Limited (ASX: CSL)

    CSL is not normally considered a strong ASX dividend share. And fair enough too – on recent prices, you can only expect a dividend yield of around 1%. But I think CSL is an underappreciated dividend star. It has increased its payouts by an average of 15% per annum since it first started sending cash out the door in 2013. If this continues, it won’t be long until CSL is a dividend heavyweight in its own right. And investors who get in early will benefit the most. As such, I think CSL is a top dividend pick today for income down the road.

    Motley Fool contributor Sebastian Bowen does not own shares in CSL Limited.

    James Mickleboro: BWP Trust (ASX: BWP) 

    I think that BWP Trust would be a great dividend option for investors in August. It is an REIT that invests in and manages commercial properties throughout Australia. The majority of its properties are leased to home improvement giant Bunnings Warehouse. These are high quality assets which have actually increased in value during the pandemic. This is quite the opposite to what is happening with most retail properties right now. In FY 2021, BWP intends to pay a distribution in the region of 18.3 cents per unit. This works out to be an attractive 4.6% yield based on the current BWP share price, at the time of writing.

    Motley Fool contributor James Mickleboro does not own shares in BWP Trust. 

    Nikhil Gangaram: Nick Scali Limited (ASX: NCK)

    Nick Scali is my dividend pick for August. Despite the chaos caused by the COVID-19 pandemic, the furniture retailer recently surprised the market with its results for FY20, whilst also predicting a bumper FY21.

    For the 12 months to 30 June, Nick Scali reported revenue of $262.5 million and net profit of $42.1 million. In addition, the company cited a strong order book and expects earnings to jump 50% for the first half of FY21. As a result, Nick Scali increased its final dividend by 12.5%, with the company set to pay out 22.5 cents per share.

    Motley Fool contributor Nikhil Gangaram does not own shares in Nick Scali Limited.  

    Daniel Ewing: AGL Energy Limited (ASX: AGL)

    AGL has been hard hit by the pandemic, despite it traditionally being considered a safe haven asset. AGL operates and owns Australia’s largest energy generating portfolio. Thus, it is convenient that the public’s need for electricity is incessant. Furthermore, Victoria is having to endure a second lock down in the middle of winter. Shareholders will be hoping this causes an uptick in utility consumption that will provide a meaningful boost to earnings for the energy giant. AGL currently offers a trailing dividend of 6.52% on current prices. With franking at 80%, the yield is nothing to be scoffed at.

    Motley Fool contributor Daniel Ewing does not own shares in AGL Energy Limited.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    The post Top ASX dividend shares to buy in August 2020 appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31DHDqs

  • The Trends At Dollar General (NYSE:DG) That You Should Know About

    The Trends At Dollar General (NYSE:DG) That You Should Know AboutIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd…

    from Yahoo Finance https://ift.tt/33SzwJl

  • Pfenex Pops 59% On Ligand $513M Buy-Out Deal; Analyst Sees 93% Upside

    Pfenex Pops 59% On Ligand $513M Buy-Out Deal; Analyst Sees 93% UpsideLigand Pharmaceuticals has entered into an agreement to buy Pfenex in an all-stock deal for a total consideration of $513 million.As part of the deal, Ligand (LGND), a revenue-generating biopharmaceutical company, will buy all outstanding shares of Pfenex at $12 per share in cash for $438 million, which represents a 57% premium to Pfenex’s closing share price on Aug. 10. Pfenex surged 59% to $12.20 in extended market trading on Monday.In addition, Ligand, will pay $2 per share or $78 million as a Contingent Value Right (CVR) in the event a predefined regulatory milestone is achieved by the end 2021. The deal, which is subject to customary conditions, is expected to close in the fourth quarter.Pfenex (PFNX) is a development and licensing biotechnology company focused on the production of enzymes, peptides, antibody derivatives and engineered non-natural proteins.“Pfenex is an ideal strategic, business and cultural fit with Ligand. The acquisition holds potential to have a significantly positive scientific and financial impact on our business in the short and long term,” said Ligand CEO John Higgins. “Pfenex will add an established, proven protein expression platform to Ligand that is highly complementary to our essential, proprietary drug discovery and formulation technologies.”Ligand expects the deal will be modestly dilutive to 2020 adjusted diluted EPS and will add $0.10 to $0.30 of adjusted diluted EPS accretion in 2021. Thereafter the biopharma company estimates that the transaction will generate “significant” annual adjusted diluted EPS accretion with the current forecast of $0.60 to $0.80 in 2022 and $1.25 to $1.50 in 2023.Ligand shares have advanced 14% so far this year. What’s more, the $179.75 average analyst price target implies another promising 52% upside potential might be lying ahead over the coming 12 months.Five-star analyst Joseph Pantginis at H.C. Wainwright last week reiterated a Buy rating on the stock with a $229 price target (93% upside potential), saying that shares continue to be undervalued.“We highlight that Ligand’s assets, both in-house and from partners, are positively advancing towards the clinic, pivotal inflection points, and may reach a certain investment verdict promptly,” Pantginis wrote in a note to investors. “Ligand continues to deliver on its promise of building future revenue streams and value for shareholders via the advancement of the shots-on-goal business strategy in hand, which includes acquiring healthy and potentially highly valuable companies, and securing key partnerships to collect royalty and milestone payments.”Overall, the rest of the Street shares Pantginis bullish outlook. The Strong Buy analyst consensus boast 4 unanimous Buy ratings. (See LGND stock analsys on TipRanks)Related News: MGM Spikes 14% As IAC Makes $1B Investment Amid Online Gambling Bet Roper Looking To Snap Up Vertafore For $5.5 Billion- Report Tilray Plunges 10% As Canadian Cannabis Market Remains Under Pressure More recent articles from Smarter Analyst: * IBM Inks Multiyear Hybrid Cloud Deal With Coca-Cola European Enterprises * RBC Capital: Why Shopify Deserves To Move Even Higher * Occidental Petroleum Posts $8.4 Billion Loss in 2Q Amid Oil Price Crisis * Royal Caribbean Rises In Pre-Market On Higher Demand For 2021 Cruises

    from Yahoo Finance https://ift.tt/2DGng40

  • Vuzix Reports Record Smart Glasses Revenues and Provides Business Outlook

    Vuzix Reports Record Smart Glasses Revenues and Provides Business OutlookVuzix Smart Glasses revenues for the second quarter increased 183% year-over-yearOverall revenues for the second quarter increased 98% sequentially compared to the first quarterROCHESTER, N., Aug.

    from Yahoo Finance https://ift.tt/3itmDtc

  • Walmart vs Target: Which Retailer is the Better Buy?

    Walmart vs Target: Which Retailer is the Better Buy?E-commerce players, especially Amazon, have disrupted the retail space over the past few years and led to the bankruptcy of several brick-and-mortar retailers. However, Walmart and Target continue to grow and adapt to changing industry dynamics.The COVID-19 pandemic led to consumers piling up groceries and other essentials amid lockdowns. This stockpiling benefited the sales of certain categories of Walmart and Target. E-commerce sales of both companies witnessed a sharp spike in the fiscal first quarter. However, sales of certain discretionary items took a hit.Walmart and Target are set to announce their fiscal second-quarter results soon. Analysts expect strong e-commerce sales and some improvement in physical store sales due to easing of the lockdown restrictions.Using TipRanks’ Stock Comparison tool, we lined up the two alongside each other to analyze what the near-term holds for these big-box retailers. Walmart (WMT)Walmart has sustained its leadership position in a highly competitive retail landscape due to its continued focus on low prices and aggressive investments in e-commerce. The company’s cost control and productivity efforts have also helped in improving its performance.Walmart’s FQ1 2021 (Feb to April quarter) revenue increased 8.6% year-over-year to $134.6 billion. The company’s US comparable sales surged 10% thanks to pandemic-led demand for food and essentials. Towards the end of the quarter, the company also saw higher sales in categories like video games, toys and televisions as people were restricted to their homes.Indeed, the retail giant was already experiencing strong e-commerce growth. But the COVID-19 pandemic took the e-commerce sales to another level. The company’s first quarter US e-commerce sales surged 74%. Notably, focus on online grocery helped in boosting digital sales.However, costs to support increased workforce and additional benefits impacted the company’s first-quarter profitability. Walmart hired over 235,000 new associates in the US. The first-quarter gross margin was also hurt by a spike in sales of lower-margin categories.UBS analyst Michael Lasser believes that Walmart’s strong performance likely continued through the second quarter. He expects a 6% comparable sales growth in the second quarter, which is higher than the 5.5% consensus. The five-star analyst also feels that the food-at-home trend amid the coronavirus crisis would continue to benefit Walmart’s grocery sales.He explained, “WMT’s commitment to its EDLP [Every Day Low Price] strategy likely drove value for its customers, especially at a time when many competitors decreased promotions, thereby raising prices. Also, its SSS [Same Store Sales] likely benefited from robust digital sales (we model 55% digital sales growth at Walmart US) as more shoppers favored ordering online.” As a result, the analyst reiterated his Buy rating with a price target of $135 on August 4.Overall, 18 Buy ratings and 5 Holds assigned in the last three months add up to a bullish ‘Strong Buy’ analyst consensus for Walmart stock. With an average price target of $140.58, analysts see an upside of 6.6% over the coming 12-months. (See Walmart stock analysis on TipRanks) Target (TGT)Like its rival Walmart, Target also gained from the spike in the demand for groceries since the implementation of at-home restrictions due to COVID-19. However, it is notable that Target has a lower exposure to groceries compared to Walmart.Target’s FQ1 2020 revenue increased 11.3% year-over-year to $19.6 billion. The company’s comparable sales grew 10.8% essentially due to a 141% rise in digital sales while store comparable sales grew by just 0.9%.Its same-day delivery services, comprising Order Pick Up, Drive Up and Shipt services, boosted the company’s e-commerce sales as customers avoided going to the stores to curb the spread of the coronavirus. These fulfillment services helped the company’s e-commerce site win 5 million new customers in the first quarter. Target’s acquisition of last-mile platform from start-up Deliv is expected to further enhance its delivery capabilities.However, Target’s first-quarter margins took a hit as demand for higher-margin merchandise like apparel slowed down and less profitable categories like food and essentials grew. Also, higher wages and benefits to support employees weighed on the bottom line.Meanwhile, Cowen analyst Oliver Chen is optimistic about Target’s prospects owing to its exposure to home décor, food, and essentials. He notes “We acknowledge some weakness in the back-to-school portion of Home, but believe shoppers nesting at home will be a key category driver over the coming quarters.”  The analyst expects the company’s fulfillment capabilities to favor its performance. The four-star analyst reaffirmed his Buy rating for Target stock on August 4 with a price target of $150.The rest of the Street has a cautiously optimistic ‘Moderate Buy’ analyst consensus for Target stock with 10 Buy ratings, 5 Holds, and one Sell. At $130.27, the average price target implies a 2.01% downside potential lies ahead. (See Target stock analysis on TipRanks)Bottom Line Looking at the stock gain over the past one-year, Target has delivered higher returns compared to Walmart. However, based on Wall Street consensus and upside potential, Walmart currently seems to be the better choice.To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment More recent articles from Smarter Analyst: * Occidental Petroleum Posts $8.4 Billion Loss in 2Q Amid Oil Price Crisis * Royal Caribbean Rises In Pre-Market On Higher Demand For 2021 Cruises * Pfenex Pops 59% On Ligand $513M Buy-Out Deal; Analyst Sees 93% Upside * American Airlines Shares Lifted By Air Travel Demand Data

    from Yahoo Finance https://ift.tt/31IXXGi

  • What Silvercorp Metals Inc.’s (TSE:SVM) P/E Is Not Telling You

    What Silvercorp Metals Inc.'s (TSE:SVM) P/E Is Not Telling YouWith a price-to-earnings (or "P/E") ratio of 37.6x Silvercorp Metals Inc. (TSE:SVM) may be sending very bearish…

    from Yahoo Finance https://ift.tt/2XNj3CA

  • Shift to Telehealth Drives Record Revenue and Gross Profit in Second Quarter 2020

    Shift to Telehealth Drives Record Revenue and Gross Profit in Second Quarter 2020* WELL achieved record quarterly patient services revenues in the second quarter due to: (1) a successful shift to telehealth which included significant revenues from both VirtualClinic+ and phone consultations; (2) WELL's family practice business proved to be highly resilient; and (3) WELL's corporate-owned clinics remained open as a critical business throughout the COVID-19 pandemic. * COVID-19 has caused an acceleration of WELL's telehealth business as patients observing physical distancing measures increasingly turned to telehealth during the pandemic.

    from Yahoo Finance https://ift.tt/2DFaHpu

  • Tilray Plunges 10% As Canadian Cannabis Market Remains Under Pressure

    Tilray Plunges 10% As Canadian Cannabis Market Remains Under PressureShares in Canadian pharmaceutical and cannabis company Tilray (TLRY) plunged 10% in Monday’s after-hours trading on mixed second quarter earning results. The stock had climbed 7% during the day in the build up to the print.Specifically, Q2 GAAP EPS of -$0.66 missed Street expectations by $0.39. Meanwhile revenue of $50.4M missed by $4.59M (despite rising 10% year-over-year) due primarily to challenges in the Canadian Recreational market. Revenue declined 3% sequentially from Q1 driven by the impact of COVID-19 and a limited number of retail store additions in Q2.“With our significant cost cutting and balance sheet actions behind us, we have positioned Tilray to enter the second half of 2020 in a stronger position so we can remain focused on achieving profitable growth in all our markets and deliver break-even or positive Adjusted EBITDA in the fourth quarter of 2020” commented Brendan Kennedy, Tilray’s CEO.On the positive side, an adjusted EBITDA loss of $12.3M (vs. an $18.0M loss in the prior year) came in ahead of Street expectations for a $14.6M loss. Total cannabis kg equivalents sold also surged 105% year-over-year to 11,430 kgs.Notably, Q2 International Medical revenue increased 349% to $8.3M from $1.9M in the prior year, up from a 220% increase in Q1. Revenue growth for the other cannabis segments was as follows: Canada Medical +65%, Adult Use +17%, and Bulk -94%. (See TLRY stock analysis on TipRanks).Following the results Oppenheimer analyst Rupesh Parikh reiterated his hold rating without a price target. “The company continues to drive strong growth in international medical, but the performance in Canada remains a key focal point for us going forward… [we] continue to model an adjusted EBITDA loss in Q4 primarily driven by the difficult competitive backdrop in Canada” he explained.Overall the stock scores a cautious Hold analyst consensus with 6 recent hold ratings vs just 1 buy rating. The average analyst price target of $9 indicates upside potential of 9%, with shares currently down 53% year-to-date. As MKM Partners analyst Bill Kirk writes, “The sooner Tilray can derive the majority of its sales from Europe with product grown in Portugal, the better.”Related News: Amarin’s Vascepa To Take Part In Covid-19 Study In Adults With Heart Disease Regeneron Prices $1.25B Public Offering; Analyst Cautious On Valuation Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab More recent articles from Smarter Analyst: * American Airlines Shares Lifted By Air Travel Demand Data * Walmart vs Target: Which Retailer is the Better Buy? * RBC Raises TripAdvisor’s PT On Improving Demand Outlook * Inovio To Start Phase 2/3 Study Of Covid-19 Candidate In Sept.; Shares Drop 8%

    from Yahoo Finance https://ift.tt/3ioGaem